News in brief: ILD therapy nintedanib recommended for PBS listing; Corticosteroids in doubt for elderly COVID patients; Patient communication suffers if physicians can’t mentally multitask

ILD therapy nintedanib recommended for PBS listing Nintedanib (Ofev) capsules have been recommended for PBS listing for the treatment of patients with progressive fibrosing interstitial lung disease (PF-ILD). At its September meeting the Pharmaceutical Benefits Advisory Committee (PBAC) recommended the listing of the drug produced by Boehringer Ingelheim, saying it was satisfied that nintedanib provided ...

Already a member?

Login to keep reading.

© 2021 the limbic